PP_1170x120_10-25-21

completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity.

GSK’s consumer health spinoff Haleon debuts

GSK’s consumer health spinoff Haleon debuts

WARREN, N.J. — Haleon has launched Monday as an independent company 100% focused on consumer health, completing its demerger from GSK. The newly listed business is driven by its purpose to deliver better everyday health with humanity. Trading commenced on Monday on the London Stock Exchange (LSE), with Brian McNamara, CEO of Haleon, leading the